No Data
No Data
Nanwei Corporation (603880.SH): The individual first aid kit has not yet carried out export trade business.
On August 6, Gelunhui reported that Nanwei Corporation (603880.SH) stated on the interactive platform that the company has not yet launched export trade business for its individual first-aid kits.
Jiangsu Nanfang Medical (603880.SH): Revocation of other risk warnings and suspension
On June 24th, Gelunhui reported that according to the relevant regulations of the Shanghai Stock Exchange Listing Rules, the company's stocks will be suspended from trading for 1 day starting from June 25, 2024, and will resume trading and cancel other risk warnings on June 26, 2024. After canceling other risk warnings, the company's stocks will be traded on the risk warning board. The stock abbreviation will be changed from "ST Nanwei" to "Nanwei Shares", and the daily trading limit for the company's stock will be changed from 5% to 10%. The stock code remains 603880.
Jiangsu Nanfang Medical (603880.SH) stock applies to cancel other risk warnings.
Jiangsu Nanfang Medical (603880.SH) announced that, according to the relevant provisions of the Shanghai Stock Exchange Listing Rules (revised in 2024), other risk warnings involving the company have been eliminated, and there is no situation of triggering other risk warnings. Therefore, the company has applied to the Shanghai Stock Exchange to cancel the other risk warnings imposed on the company's stock.
ST Nanwei (603880.SH) announced first-quarter results, net profit of 1.75 million yuan, a year-on-year decrease of 74.82%
ST Nanwei (603880.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 1.3 during the reporting period...
ST Nanwei (603880.SH) announced 2023 annual results with a net loss of 147 million yuan
According to the Zhitong Finance App, ST Nanwei (603880.SH) disclosed the 2023 annual report. The company achieved revenue of 600 million yuan in 2023, an increase of 10.03%; net profit loss to mother was 147 million yuan, an increase over the previous year; loss after deducting non-net profit of 147 million yuan, a year-on-year increase; and basic earnings per share were -0.51 yuan. During the reporting period, the company's main business revenue increased slightly compared to last year; the decrease in net profit attributable to the parent company was mainly due to an oversupply of protective equipment, and price competition was intense; credit impairment losses and asset impairment losses increased.
ST Nanwei (603880.SH): There is no business involved in the AI medical field yet
Gelonghui, March 19丨ST Nanwei (603880.SH) said on the investor interactive platform that the company has no business involved in the AI medical field yet.
No Data